Multiple sclerosis progression: time for a new mechanism-driven frameworkTanja Kuhlmann, Emmaunelle Waubant, Marcello Moccia et al.|The Lancet Neurology|2022Cited by 624
Cell-based therapeutic strategies for multiple sclerosisNeil Scolding, Stefano Pluchino, Marcelo C. Pasquini et al.|Brain|2017Cited by 169
Spinal cord involvement in multiple sclerosis and neuromyelitis optica spectrum disordersOlga Ciccarelli, Daniel H. Reich, Frederik Barkhof et al.|The Lancet Neurology|2019Cited by 169